Cargando…

Trans-Lycopene and β-Cryptoxanthin Intake and Stomach Cancer in Vietnamese Men: A Pilot Case-Control Study

OBJECTIVE: To examine the association between dietary intake of Trans-Lycopene and β-Cryptoxanthin and stomach cancer in Vietnamese men. METHODS: A case-control study including 80 male incident stomach cancer cases and 146 male controls was performed in a general hospital in Viet Nam. A validated se...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengngam, Khanpaseuth, Hoc, Tran Hieu, Hang, Dao Viet, Ngoan, Le Tran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360964/
https://www.ncbi.nlm.nih.gov/pubmed/35345357
http://dx.doi.org/10.31557/APJCP.2022.23.3.861
_version_ 1784764425534701568
author Sengngam, Khanpaseuth
Hoc, Tran Hieu
Hang, Dao Viet
Ngoan, Le Tran
author_facet Sengngam, Khanpaseuth
Hoc, Tran Hieu
Hang, Dao Viet
Ngoan, Le Tran
author_sort Sengngam, Khanpaseuth
collection PubMed
description OBJECTIVE: To examine the association between dietary intake of Trans-Lycopene and β-Cryptoxanthin and stomach cancer in Vietnamese men. METHODS: A case-control study including 80 male incident stomach cancer cases and 146 male controls was performed in a general hospital in Viet Nam. A validated semi-quantitative food frequency (SQFFQ) and demographic lifestyle questionnaire were designed, and venous blood samples were collected to determine H. pylori status by IgG ELISA. Nutrient intake was converted using the data of SQFFQ and the Nutritive Composition Table of Vietnamese Foods, updated in 2019. The respective associations between Trans-Lycopene and β-Cryptoxanthin intake and stomach cancer were examined using unconditional logistic regression analysis with adjustments for possible cofactors. RESULTS: Both Trans-Lycopene and β-Cryptoxanthin intake and stomach cancer showed a significantly inverse association, tertile-3 versus tertile-1, (OR = 0.15, 95%CI: 0.06–0.35, p trend = 0.00) and (OR = 0.34, 95%CI: 0.14–0.79, p trend = 0.02, respectively). For Trans-Lycopene intake stratifying by H. pylori status remained the benefit effect against stomach cancer among H. pylori-negative participants (OR = 0.15, 95%CI: 0.03–0.69, p trend = 0.02) and H. pylori-positive participants (OR = 0.13, 95%CI: 0.04–0.42, p trend = 0.00). CONCLUSIONS: Both Trans-Lycopene and β-Cryptoxanthin intake showed a strong protective effect against stomach cancer. The findings suggest that these two types of fat-soluble micronutrients would be considered as an anti-cancer therapy for both primary and secondary prevention.
format Online
Article
Text
id pubmed-9360964
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-93609642022-08-10 Trans-Lycopene and β-Cryptoxanthin Intake and Stomach Cancer in Vietnamese Men: A Pilot Case-Control Study Sengngam, Khanpaseuth Hoc, Tran Hieu Hang, Dao Viet Ngoan, Le Tran Asian Pac J Cancer Prev Research Article OBJECTIVE: To examine the association between dietary intake of Trans-Lycopene and β-Cryptoxanthin and stomach cancer in Vietnamese men. METHODS: A case-control study including 80 male incident stomach cancer cases and 146 male controls was performed in a general hospital in Viet Nam. A validated semi-quantitative food frequency (SQFFQ) and demographic lifestyle questionnaire were designed, and venous blood samples were collected to determine H. pylori status by IgG ELISA. Nutrient intake was converted using the data of SQFFQ and the Nutritive Composition Table of Vietnamese Foods, updated in 2019. The respective associations between Trans-Lycopene and β-Cryptoxanthin intake and stomach cancer were examined using unconditional logistic regression analysis with adjustments for possible cofactors. RESULTS: Both Trans-Lycopene and β-Cryptoxanthin intake and stomach cancer showed a significantly inverse association, tertile-3 versus tertile-1, (OR = 0.15, 95%CI: 0.06–0.35, p trend = 0.00) and (OR = 0.34, 95%CI: 0.14–0.79, p trend = 0.02, respectively). For Trans-Lycopene intake stratifying by H. pylori status remained the benefit effect against stomach cancer among H. pylori-negative participants (OR = 0.15, 95%CI: 0.03–0.69, p trend = 0.02) and H. pylori-positive participants (OR = 0.13, 95%CI: 0.04–0.42, p trend = 0.00). CONCLUSIONS: Both Trans-Lycopene and β-Cryptoxanthin intake showed a strong protective effect against stomach cancer. The findings suggest that these two types of fat-soluble micronutrients would be considered as an anti-cancer therapy for both primary and secondary prevention. West Asia Organization for Cancer Prevention 2022-03 /pmc/articles/PMC9360964/ /pubmed/35345357 http://dx.doi.org/10.31557/APJCP.2022.23.3.861 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. https://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Research Article
Sengngam, Khanpaseuth
Hoc, Tran Hieu
Hang, Dao Viet
Ngoan, Le Tran
Trans-Lycopene and β-Cryptoxanthin Intake and Stomach Cancer in Vietnamese Men: A Pilot Case-Control Study
title Trans-Lycopene and β-Cryptoxanthin Intake and Stomach Cancer in Vietnamese Men: A Pilot Case-Control Study
title_full Trans-Lycopene and β-Cryptoxanthin Intake and Stomach Cancer in Vietnamese Men: A Pilot Case-Control Study
title_fullStr Trans-Lycopene and β-Cryptoxanthin Intake and Stomach Cancer in Vietnamese Men: A Pilot Case-Control Study
title_full_unstemmed Trans-Lycopene and β-Cryptoxanthin Intake and Stomach Cancer in Vietnamese Men: A Pilot Case-Control Study
title_short Trans-Lycopene and β-Cryptoxanthin Intake and Stomach Cancer in Vietnamese Men: A Pilot Case-Control Study
title_sort trans-lycopene and β-cryptoxanthin intake and stomach cancer in vietnamese men: a pilot case-control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360964/
https://www.ncbi.nlm.nih.gov/pubmed/35345357
http://dx.doi.org/10.31557/APJCP.2022.23.3.861
work_keys_str_mv AT sengngamkhanpaseuth translycopeneandbcryptoxanthinintakeandstomachcancerinvietnamesemenapilotcasecontrolstudy
AT hoctranhieu translycopeneandbcryptoxanthinintakeandstomachcancerinvietnamesemenapilotcasecontrolstudy
AT hangdaoviet translycopeneandbcryptoxanthinintakeandstomachcancerinvietnamesemenapilotcasecontrolstudy
AT ngoanletran translycopeneandbcryptoxanthinintakeandstomachcancerinvietnamesemenapilotcasecontrolstudy